Profound Medical Corp.

NASDAQ:PROF

Medical - Devices

Healthcare
$6.91 +4.11%

+$0.27 today

Market cap
$253.09M
Beta
0.52
P/E (TTM)
-6.3
EPS (TTM)
-$1.07
52W Low $3.76High $8.95

Volume 0.08M

Average 0.12M

PROF Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Profound Medical Corp.NASDAQ: PROF

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) grows in line with its trailing trend

Q1 FY2026 weighted avg shares (diluted) of 36.3M shares rose 20.8% year over year, in line with the +21.2% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 18.1% from the prior quarter. Over 3 fiscal years it compounded at +13.2% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +20.8% toward the trailing-twelve-month pace of +21.2%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
36.3M+18.1% QoQ
Last fiscal yearDec 2025
30.23M+22.1% YoY
LTMMar 2026
31.8M+21.2% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+20.8%——
1 year+22.1%——
3-year CAGR+13.2%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
30.23M USD
Year-over-year change
+22.1%
4-year CAGR
+10.2%

Weighted Avg Shares (Diluted) vs competitors

How PROF compares with its peers on the latest reported figures

  • PROF's LTM Mar 2026 weighted avg shares (diluted) of 31.8M shares is the 8th highest of the 11 companies compared; the peer median is 49.37M shares.
  • Its year-over-year change of +21.2% is the 4th highest of 11, against a peer median of +10.6%.
  • Over three fiscal years its annual growth of +13.2% compares with a peer median of +8.0%.
PROF Competitors Peer median
Weighted Avg Shares (Diluted) for PROF and competitors
Company Period LTM YoY 3-year CAGR
OWLTOwlet, Inc.LTM Mar 2026149.39M +1085.6%+313.6%
MXCTMaxCyte, Inc.LTM Mar 2026106.51M +1.3%+1.5%
STIMNeuronetics, Inc.LTM Mar 202667.96M +71.5%+34.8%
NNOXNano-X Imaging Ltd.LTM Dec 202564.81M +10.5%+7.4%
CATXPerspective Therapeutics, Inc.LTM Mar 202654.95M -21.6%+10.4%
TLSITriSalus Life Sciences, Inc.LTM Mar 202643.78M +66.1%+8.6%
ARMPArmata Pharmaceuticals, Inc.LTM Mar 202636.32M -23.4%+1.9%
PROFProfound Medical Corp.LTM Mar 202631.8M +21.2%+13.2%
AVRAnteris Technologies Global Corp.LTM Mar 202623.58M -20.8%-13.1%
PREPrenetics Global LimitedLTM Mar 202615.04M +18.8%+40.5%
LNSRLENSAR, Inc.LTM Mar 202612.87M +10.8%+5.6%
Peer median (excluding PROF) 49.37M+10.6%+8.0%

Competitors are the stored peer set for PROF. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue6.87M6.68M7.2M10.17M16.38M
Cost of Revenue3.92M3.66M2.82M3.47M4.79M
Gross Profit2.95M3.02M4.38M6.7M11.59M
Gross Margin43.0%45.2%60.9%65.9%70.8%
Research & Development15.28M14.69M14.38M16.15M20.96M
Selling, General & Admin17.97M17.93M18.62M22.02M32.61M
Operating Expenses33.24M35.15M33M38.17M53.57M
Depreciation & Amortization1.88M1.6M1.15M891.06K569.8K
EBITDA(28.65M)(26.6M)(26.78M)(25.59M)(41.41M)
EBITDA Margin-416.8%-398.2%-372.0%-251.7%-252.8%
Operating Income(30.29M)(32.13M)(28.62M)(31.47M)(41.98M)
Operating Margin-440.7%-480.9%-397.5%-309.6%-256.3%
Interest Income203.2K1.05M1.64M1.37M1.09M
Interest Expense66.41K167.11K770K00
Other Income / Expenses(303K)3.74M(81K)4.99M(1.08M)
Income Before Tax(30.59M)(28.38M)(28.7M)(26.48M)(43.06M)
Pre-Tax Margin-445.1%-424.8%-398.6%-260.5%-262.9%
Income Tax Expense105K287K(128K)(1.9K)256.41K
Net Income(30.7M)(28.67M)(28.57M)(26.48M)(43.32M)
Net Margin-446.7%-429.1%-396.8%-260.4%-264.4%
EPS (Basic)(1.50)(1.38)(1.35)(1.07)(1.43)
EPS (Diluted)(1.50)(1.38)(1.35)(1.07)(1.43)
Weighted Avg Shares20.46M20.83M21.18M24.77M30.23M
Weighted Avg Shares (Diluted)20.47M20.83M21.18M24.77M30.23M

Profound Medical Corp.

NASDAQ:PROF

Intrinsic Alpha fair value

Locked

Current Price

$6.91

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.